P J Snow. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAgedHumansMiddle AgedMortalityMyocardial Infarction/drug therapyParasympatholytics/adverse effectsParasympatholytics/therapeutic usePrognosisPropranolol/therapeutic use
Substances: See more » ParasympatholyticsPropranolol
Year: 1965 PMID: 4158187 DOI: 10.1016/s0140-6736(65)90863-9
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321